Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer

NCT00148070 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Docetaxel
PROCEDURE: Erythromycin Breath Test (ERMBT)

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]
[object Object]